HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).

AuthorsM Humbert, O Sanchez, M Fartoukh, J L Jagot, O Sitbon, G Simonneau
JournalChest (Chest) Vol. 114 Issue 1 Suppl Pg. 80S-82S (Jul 1998) ISSN: 0012-3692 [Print] United States
PMID9676646 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Epoprostenol
Topics
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Connective Tissue Diseases (complications, physiopathology)
  • Epoprostenol (administration & dosage, therapeutic use)
  • Hemodynamics (drug effects)
  • Humans
  • Hypertension, Pulmonary (etiology, physiopathology)
  • Infusions, Intravenous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: